The following pages link to Marc Buyse (Q1029798):
Displaying 22 items.
- Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points (Q87467) (← links)
- Exploring and validating surrogate endpoints in colorectal cancer (Q1029801) (← links)
- Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials (Q1658329) (← links)
- The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials (Q2475730) (← links)
- Statistical evaluation of surrogate endpoints with examples from cancer clinical trials (Q2792764) (← links)
- An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference (Q2827172) (← links)
- Predicting Treatment Effect from Surrogate Endpoints and Historical Trials: An Extrapolation Involving Probabilities of a Binary Outcome or Survival to a Specific Time (Q2894011) (← links)
- Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints (Q3445296) (← links)
- On the relationship between the causal‐inference and meta‐analytic paradigms for the validation of surrogate endpoints (Q3465713) (← links)
- Validation of a longitudinally measured surrogate marker for a time-to-event endpoint (Q3591808) (← links)
- (Q3687570) (← links)
- Simplified hierarchical linear models for the evaluation of surrogate endpoints (Q4432903) (← links)
- The validation of surrogate endpoints in meta-analyses of randomized experiments (Q4489920) (← links)
- Criteria for the Validation of Surrogate Endpoints in Randomized Experiments (Q4666043) (← links)
- Validation of Surrogate Endpoints in Multiple Randomized Clinical Trials with Discrete Outcomes (Q5121917) (← links)
- A perspective on surrogate endpoints in controlled clinical trials (Q5424596) (← links)
- A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisons (Q6071296) (← links)
- Correcting the bias of the net benefit estimator due to right‐censored observations (Q6091712) (← links)
- Generalized pairwise comparisons for censored data: an overview (Q6550308) (← links)
- Minimization in randomized clinical trials (Q6560530) (← links)
- Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: a simulation study (Q6627908) (← links)
- Individualized net benefit estimation and meta-analysis using generalized pairwise comparisons in \(N\)-of-1 trials (Q6629973) (← links)
